Cumberland Pharmaceuticals Inc. Payments of Financing Costs
Cumberland Pharmaceuticals Inc. (CPIX) reported Payments of Financing Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2022-03-11
- Cumberland Pharmaceuticals Inc. payments of financing costs for the quarter ending 2010-12-31 was $27.50K.
- Cumberland Pharmaceuticals Inc. payments of financing costs for the quarter ending 2010-09-30 was $27.50K.
- Cumberland Pharmaceuticals Inc. payments of financing costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. payments of financing costs for fiscal 2020 was $10.00K, a 80.95% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. payments of financing costs for fiscal 2019 was $52.50K.
- Cumberland Pharmaceuticals Inc. payments of financing costs for fiscal 2018 was $0.00.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 | |||
| 2020-12-31 | $10.00K 10-K · filed 2022-03-11 | |||
| 2019-12-31 | $52.50K 10-K · filed 2022-03-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 | |||
| 2017-12-31 | $0.00 8-K · filed 2020-12-10 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-09 | |||
| 2015-12-31 | $1.67M 10-K · filed 2018-03-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-13 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-11 | |||
| 2011-12-31 | $17.64K 10-K · filed 2014-03-11 | |||
| 2010-12-31 | $27.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $55.00K derived: sum of 2 quarters · filed 2013-03-12 | $110.00K 10-K · filed 2013-03-12 | |
| 2010-09-30 | $27.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $82.50K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $55.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $189.66K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |